Economics at your fingertips  

Details about Katharina Elisabeth Blankart

Workplace:Hamburg Center for Health Economics (HCHE), Universität Hamburg (University of Hamburg), (more information at EDIRC)
Deutsches Forschungszentrum für Gesundheitsökonomik (CINCH) (Health Economics Research Center), Fachbereich Wirtschaftswissenschaften (Faculty of Economics and Business Administration), Universität Duisburg-Essen (University of Duisburg-Essen), (more information at EDIRC)

Access statistics for papers by Katharina Elisabeth Blankart.

Last updated 2023-09-15. Update your information in the RePEc Author Service.

Short-id: pfi221

Jump to Journal Articles

Working Papers


  1. The Effects of Off-label Drug Use on Disability and Medical Expenditure
    NBER Working Papers, National Bureau of Economic Research, Inc Downloads
    Also in Ruhr Economic Papers, RWI - Leibniz-Institut für Wirtschaftsforschung, Ruhr-University Bochum, TU Dortmund University, University of Duisburg-Essen (2022) Downloads


  1. A Hard Look at “Soft” Cost‐control Measures in Healthcare Organizations: Evidence from Preferred Drug Policies in Germany
    CINCH Working Paper Series (since 2020), Duisburg-Essen University Library, DuEPublico Downloads
    Also in Working Papers, Centre for Health Economics, Monash University (2021) Downloads

Journal Articles


  1. Arzneimittel: Placebo bei Engpassbekämpfung
    (Pharmaceuticals: Placebo in combating bottlenecks)
    Wirtschaftsdienst, 2022, 102, (4), 248-248 Downloads


  1. Regional Innovation Systems of Medical Technology: A knowledge production function of cardiovascular research and funding in Europe
    REGION, 2021, 8, 57-81 Downloads


  1. Are patients more adherent to newer drugs?
    Health Care Management Science, 2020, 23, (4), 605-618 Downloads View citations (2)
  2. Physician-Level Cost Control Measures and Regional Variation of Biosimilar Utilization in Germany
    IJERPH, 2020, 17, (11), 1-14 Downloads View citations (2)
  3. The impact of drug quality ratings from health technology assessments on the adoption of new drugs by physicians in Germany
    Health Economics, 2020, 29, (S1), 63-82 Downloads View citations (3)


  1. The impact of physician-level drug budgets on prescribing behavior
    The European Journal of Health Economics, 2018, 19, (2), 213-222 Downloads View citations (8)


  1. Dispensing behaviour of pharmacies in prescription drug markets
    Health Policy, 2016, 120, (2), 190-197 Downloads
  2. Drug safety and the impact of drug warnings: An interrupted time series analysis of diabetes drug prescriptions in Germany and Denmark
    Health Policy, 2016, 120, (12), 1404-1411 Downloads
  3. Health benefit assessment of pharmaceuticals: An international comparison of decisions from Germany, England, Scotland and Australia
    Health Policy, 2016, 120, (10), 1115-1122 Downloads View citations (8)
  4. The diffusion of generics after patent expiry in Germany
    The European Journal of Health Economics, 2016, 17, (8), 1027-1040 Downloads View citations (4)


  1. Analysing coverage decision-making: opening Pandora’s box?
    The European Journal of Health Economics, 2014, 15, (9), 899-906 Downloads View citations (2)
  2. Early Benefit Assessment of Pharmaceuticals in Germany
    Medical Decision Making, 2014, 34, (8), 1030-1047 Downloads View citations (4)
  3. Funding Decisions for Newborn Screening: A Comparative Review of 22 Decision Processes in Europe
    IJERPH, 2014, 11, (5), 1-28 Downloads


  1. Link between Process and Appraisal in Coverage Decisions
    Medical Decision Making, 2013, 33, (8), 1009-1025 Downloads
  2. Transparency vs. closed-door policy: Do process characteristics have an impact on the outcomes of coverage decisions? A statistical analysis
    Health Policy, 2013, 112, (3), 187-196 Downloads View citations (6)


  1. A systematic review of coverage decision-making on health technologies—Evidence from the real world
    Health Policy, 2012, 107, (2), 218-230 Downloads View citations (14)


  1. A structured tool to analyse coverage decisions: Development and feasibility test in the field of cancer screening and prevention
    Health Policy, 2011, 101, (3), 290-299 Downloads View citations (5)
Page updated 2023-09-16